RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 103 filers reported holding RAPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.07 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,595 | +6.4% | 1,901 | +19.7% | 0.00% | +100.0% |
| Q2 2023 | $29,696 | +1.9% | 1,588 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $29,140 | -7.3% | 1,588 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $31,442 | -17.7% | 1,588 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $38,207 | +31.8% | 1,588 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $28,981 | +4.8% | 1,588 | +26.3% | 0.00% | 0.0% |
| Q1 2022 | $27,641 | -85.9% | 1,257 | -76.4% | 0.00% | -66.7% |
| Q4 2021 | $195,661 | +18.3% | 5,327 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $165,403 | -2.3% | 5,327 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $169,345 | +42.6% | 5,327 | +44.4% | 0.00% | 0.0% |
| Q3 2020 | $118,754 | +11.0% | 3,688 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $107,026 | – | 3,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |